Answers are grounded in this paper and cite their sources.
This editorial highlights that while higher BMI may be associated with better outcomes in heart failure (the obesity paradox), increased waist-to-hip ratio (central obesity) is associated with higher mortality, particularly in women.
This article refers to ‘Waist-to-hip ratio and mortality in heart failure’ by K.W. Streng et al., published in this issue on pages 1269–1277. Obesity increases almost all of the cardiovascular disease (CVD) risk factors, including increasing the risk of hypertension and coronary heart disease (CHD), two strong risk factors for heart failure (HF).1, 2 In fact, obesity is an independent risk factor for HF, especially HF with preserved ejection fraction (HFpEF), more so than in HF with reduced ejection fraction (HFrEF). However, once HF is diagnosed, overweight and obese patients with HF generally have a better prognosis than do leaner HF patients, particularly those who are underweight, who generally have the worst prognosis, but even compared to those who have a normal weight or, especially, normal body mass index (BMI). This phenomenon has been defined the ‘obesity paradox’. The mechanisms through which obesity is associated with a better prognosis or may actually exert protective effects are, however, still unclear.1, 2 Obesity is defined by the World Health Organization (WHO) as ‘an excess fat mass that impairs health’. However, at the population level, but also in the clinical setting, obesity is typically assessed using BMI, which is considered a surrogate for adiposity, as it strongly associates with fat mass (FM) percentage in the general population and, in turn, with increased mortality. In fact, in large cohorts in primary prevention, BMI has proved to be as useful or better to predict risk as other measures of adiposity.3 In the setting of established CVD, the role of high BMI is less clear. Increased BMI is clearly a risk factor for CVD and a target for primary prevention strategies. However, many CVD, including HF, are characterized by a chronic catabolic state resulting in lean mass (LM) loss, which is in turn associated with worse clinical outcomes. Considering that increased BMI is typically associated with increased FM, but also with increased LM, a major surrogate for skeletal muscle mass (SMM), it may be plausible to hypothesize a protective effect of increased BMI in the setting of HF. For these reasons, increased BMI in HF may perhaps be considered a surrogate for increased LM, therefore overcoming the potential detrimental effects of excess adiposity alone. Nevertheless, higher BMI has been associated with better prognosis in other CVD, including hypertension, CHD, and atrial fibrillation.4-6 On the other hand, BMI not only fails to assess total body composition compartments (e.g. FM, LM and SMM), but also to determine FM distribution. Accumulation of FM in the abdomen (i.e. visceral obesity or more specifically central obesity), typically indirectly measured using waist circumference (WC) is, in fact, a major CVD risk factor. However, in patients with HFrEF, higher WC was associated with better prognosis,7, 8 whereas in a recent study of HFpEF, higher WC was associated with better prognosis in univariate analysis but increased mortality in multivariate analysis.9, 10 In this issue of the Journal, Streng and colleagues11 performed a retrospective analysis using the BIOSTAT-CHF database, in which they assessed the role of FM distribution in patients with HF, using the waist-to-hip ratio (WHR) following the WHO recommendations. The authors are congratulated for completing this important analysis to increase attention of clinicians and researchers to the effects of body composition compartments, and more specifically, FM distribution, rather than BMI alone, especially in the setting of HF. Similar to WC, WHR is a stronger indirect measure of FM distribution compared to BMI, and perhaps a better marker for CVD and metabolic risk. Streng and colleagues11 demonstrated that increased BMI was associated with improved outcomes in patients with HF with a wide range of left ventricular ejection fraction, confirming the obesity paradox in HF, in both women and men. However, when WHR was used instead of BMI, the results were opposite. Increased WHR, indicating a greater accumulation of adipose tissue in the abdomen (i.e. visceral/central obesity), was associated with a two-fold increase of all-cause mortality, especially in women and independent of BMI and other baseline factors. The effects were less pronounced in men, with a non-significant 21% mortality relative risk increase in those with greater WHR. Furthermore, the authors suggest that these detrimental effects of increased WHR may be related to a greater pro-inflammatory state. Like HF, CHD has been associated with systemic inflammation, and is the leading cause of death in postmenopausal women.4, 6 It is therefore interesting that the authors of this study reported a strong positive association between higher WHR and inflammatory markers in women. These elevated markers of inflammation may have been due to a higher chronic disease burden from co-morbidities in this population of elderly females (mean age 75 ±11 years), which may account for the higher mortality rate. However, adipose tissue promotes soluble tumour necrosis factor-α receptors which could neutralize these particles and have a protective impact. Obese patients also have higher levels of circulating lipoproteins, which may bind and detoxify lipopolysaccharides responsible for the release of inflammatory cytokines. Therefore, factors other than increased adiposity alone may account for the increased markers of inflammation, and subsequent mortality, in this cohort of female patients. Although such association seems plausible, because of the observational nature of the data, causality cannot be established at this time.1, 2, 4-6, 12 As we indicated in the recent study of patients with HFpEF,10 it would be interesting to know whether increased WHR is still a marker for poor outcomes in different BMI categories. If the results were confirmed only in patients with high WHR and normal or low BMI, that would suggest the presence of sarcopenia or sarcopenic obesity in those patients, conditions characterized by reduced LM or reduced LM and excess adiposity, respectively. Both sarcopenia and sarcopenic obesity are associated with worse outcomes in a number of chronic diseases, including HF (Figure 1).2, 12 Moreover, the authors did not assess the very important role of physical activity or, more so, cardiorespiratory fitness (CRF). Certainly, increased CRF is independently associated with improved outcomes in HF.1, 2, 12-15 In fact, the obesity paradox only seems to be present in those with low levels of CRF, whereas when CRF is relatively preserved, prognosis is considerably better, regardless of body composition (Figure 1).1, 2, 4, 10, 12-15 Whether increased CRF would overcome the detrimental effects of increased WHR remains unknown, although we have previously demonstrated that fitness markedly alters the relationship between body composition and prognosis in both CHD and HF.1, 2, 4, 10, 12-15 Further prospective studies targeting general and, specifically, abdominal obesity in both primary and secondary prevention for HF are clearly needed to determine whether it plays a causative role, or whether it is just a marker, indicating an overall poor nutritional status. The data presented by Streng and colleagues,11 however, are extremely important, especially considering that WHR assessment, only slightly less so than just WC, is a very simple and low-cost tool, and its use could be easily implemented in the clinical setting. Furthermore, the results presented suggest that targeting abdominal obesity with weight-loss strategies, including caloric restriction and exercise, with both aerobic exercise to improve CRF, as well as resistance training to increase LM and, specifically, SMM, may represent efficacious strategies in the prevention and treatment of HF. Conflict of interest: S.C. is supported by a Mentored Clinical & Population Research Award 16MCPRP31100003 from the American Heart Association, by the VCU DOIM Pilot Project Grant Program 2017 and by the VCU Pauley Heart Center Pilot Project Grant Program 2017. The other authors do not report any conflict of interest.
No takes yet. Share an insight, caveat, or question.
Carbone et al. (2018) conducted an editorial in Heart failure. Increased waist-to-hip ratio (WHR) vs. Lower WHR was evaluated on All-cause mortality (two-fold increase).
Synapse has enriched 10 related papers. Consider them for comparative context: